Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | RELA | Q04206 | 4/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10226704 | 0.97 | FAAH (0.54) | FAAHCA2RELAKDM4EHPGD | |
| SCHEMBL6501307 | 0.97 | FAAH (0.54) | FAAHCA2RELAKDM4EHPGD | |
| SCHEMBL15958664 | 0.95 | FAAH (0.46) | FAAHCA2RELACA12CA1 | |
| SCHEMBL14932179 | 0.93 | FAAH (0.50) | FAAHCA2RELAKDM4EHPGD | |
| SCHEMBL239451 | 0.92 | HPGD (0.44) | FAAHCA2RELACA12CA1 | |
| SCHEMBL13145951 | 0.87 | FAAH (0.44) | FAAHCA2RELAKDM4EHPGD | |
| SCHEMBL15177331 | 0.86 | HPGD (0.41) | FAAHCA2RELACA12CA1 | |
| SCHEMBL12386317 | 0.85 | FAAH (0.48) | FAAHCA2RELAKDM4EHPGD | |
| SCHEMBL3030769 | 0.85 | FAAH (0.48) | FAAHCA2RELAKDM4EHPGD | |
| SCHEMBL9325375 | 0.85 | FAAH (0.43) | FAAHCA2RELAKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11298649-B2 | Systems and methods incorporating ionic liquids for electrochemically mediated capturing of Lewis acid gases | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-04-12 | — | — | US | claimed |
| US-20210292196-A1 | REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2021-09-23 | — | — | US | claimed |
| US-20210206791-A1 | SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2021-07-08 | — | — | US | claimed |
| US-11045833-B2 | Task specific ionic liquid-impregnated polymeric surface coatings for antibacterial, antifouling, and metal scavenging activity | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-29 | — | — | US | claimed |
| US-20200291052-A1 | BIS-PHENANTHROLINE IRON MACROCYCLE COMPLEX FOR OXYGEN REDUCTION REACTION | UNITED STATES DEPARTMENT OF ENERGY | 2020-09-17 | — | — | US | claimed |
| WO-2020186264-A1 | BIS-PHENANTHROLINE IRON MACROCYCLE COMPLEX FOR OXYGEN REDUCTION REACTION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-09-17 | — | — | WO | claimed |
| US-20190327964-A1 | SILVER- AND COPPER-CHELATING IONIC LIQUIDS, POLYMERS, AND GELS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2019-10-31 | — | — | US | claimed |
| US-20190291043-A1 | SYSTEMS AND METHODS INCORPORATING IONIC LIQUIDS FOR ELECTROCHEMICALLY MEDIATED CAPTURING OF LEWIS ACID GASES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-09-26 | — | — | US | claimed |
| EP-3500530-A1 | REMOVAL OF METAL IONS FROM AQUEOUS SOLUTION VIA LIQUID/LIQUID EXTRACTION AND ELECTROCHEMISTRY | Massachusetts Institute Of Technology (US) | 2019-06-26 | — | — | EP | claimed |
| US-20190189364-A1 | HIGH-TEMPERATURE SUPERCAPACITORS CONTAINING SURFACE ACTIVE IONIC LIQUIDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2019-06-20 | — | — | US | claimed |
| WO-2003055878-A1 | 2-HETEROARYLCARBOXYLIC ACID AMIDES | BAYER HEALTHCARE AG (DE) | 2003-07-10 | — | — | WO | claimed |
| US-6492403-B1 | TREATING SYMPTOMS OF ACUTE OR CHRONIC DISORDER MEDIATED BY CLASSICAL PATHWAY OF COMPLEMENT CASCADE; PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-12-10 | — | — | US | claimed |
| US-20020037915-A1 | Compounds and compositons for treating C1s-mediated diseases and conditions | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-03-28 | — | — | US | claimed |
| EP-1152759-A2 | METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-11-14 | — | — | EP | claimed |
| EP-1150979-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-11-07 | — | — | EP | claimed |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | ILLIG CARL R (US) | 2001-10-18 | — | — | US | claimed |
| US-6291514-B1 | Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2001-09-18 | — | — | US | claimed |
| WO-2000047194-A9 | METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR | DIMENSIONAL PHARM INC (US) | 2001-05-31 | — | — | WO | claimed |
| WO-2000047578-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| WO-2000047194-A2 | METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037915-A1 | Compounds and compositons for treating C1s-mediated diseases and conditions | C1S, C1R, C9 | FAAH 1167/4885CA2 820/4885RELA 283/4885 |
| US-20190291043-A1 | SYSTEMS AND METHODS INCORPORATING IONIC LIQUIDS FOR ELECTROCHEMICALLY MEDIATED CAPTURING OF LEWIS ACID GASES | CA13, CA1, CA12 | FAAH 1551/4885CA2 6/4885RELA 3275/4885 |
| US-11045833-B2 | Task specific ionic liquid-impregnated polymeric surface coatings for antibacterial, antifouling, and metal scavenging activity | LPO, SOD1, ICMT | FAAH 2662/4885CA2 2948/4885RELA 2685/4885 |
| US-20200291052-A1 | BIS-PHENANTHROLINE IRON MACROCYCLE COMPLEX FOR OXYGEN REDUCTION REACTION | CYC1, PPOX, MT-CO2 | FAAH 4773/4885CA2 429/4885RELA 2491/4885 |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | SERPINE1, PRSS3, PRSS2 | FAAH 1983/4885CA2 2597/4885RELA 4783/4885 |
| US-20210206791-A1 | SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES | SCLY, SELENOI, PTMS | FAAH 4205/4885CA2 1118/4885RELA 4647/4885 |
| US-20190327964-A1 | SILVER- AND COPPER-CHELATING IONIC LIQUIDS, POLYMERS, AND GELS, AND USES THEREOF | SOD1, AOC1, SOD3 | FAAH 4332/4885CA2 2070/4885RELA 2189/4885 |
| US-11298649-B2 | Systems and methods incorporating ionic liquids for electrochemically mediated capturing of Lewis acid gases | CA13, CA1, CA12 | FAAH 1551/4885CA2 6/4885RELA 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.